Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 9/2007

01-09-2007 | Research Articles

Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases

Authors: C. Conill, J. Berenguer, M. Vargas, A. López-Soriano, I. Valduvieco, J. Marruecos, R. Vilella

Published in: Clinical and Translational Oncology | Issue 9/2007

Login to get access
Metadata
Title
Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases
Authors
C. Conill
J. Berenguer
M. Vargas
A. López-Soriano
I. Valduvieco
J. Marruecos
R. Vilella
Publication date
01-09-2007
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 9/2007
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-007-0108-2

Other articles of this Issue 9/2007

Clinical and Translational Oncology 9/2007 Go to the issue

Educational Series

Molecular markers in colorectal cancer: genetic bases for a customised treatment

Case Reports

Pancreatic metastases from ductal and lobular carcinomas of the breast

Review

Docetaxel-induced interstitial pneumonitis following non-small-cell lung cancer treatment

Review

Effect of surgical resection of metastatic disease on immune tolerance to cancer. How a systemic disease could be controlled by a local therapy

Editorial

An update into the pathophysiological role of HER2 in cancer: therapeutic implications

Research Articles

Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits